Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Milestone
1
Aug 21, 2010 07:32PM
5
Aug 22, 2010 07:31AM

The proposal must be received at the company's principal executive offices not less than 120 calendar days before the date of the company's proxy statement released to shareholders in connection with the previous year's annual meeting

i.e. Not less than 120 days before December 8 (2009) 2010.
.
.
.
Be well

Aug 22, 2010 07:29PM
Share
New Message
Please login to post a reply